A Clinical Trial of the Accuracy and Treatment Experience of the Dexcom G4 Sensor (Dexcom G4 System) and Enlite Sensor (Guardian REAL-TIme System) Tested Simultaneously in Ambulatory Patients with Type 1 Diabetes

摘要

Background: Continuous glucose monitoring (CGM) is a tool widely used in the treatment of patients with type 1 diabetes. The purpose of the current study was to evaluate whether accuracy and patient treatment satisfaction differ between the Enlite~(TM) (Medtronic MiniMed, Inc., Northridge, CA) and Dexcom~R (San Diego. CA) G4 PLATINUM CGM sensors.Subjects and Methods: Thirty-eight ambulatory patients with type 1 diabetes used the Dexcom G4 and Enlite sensors simultaneously for a minimum of 4 and maximum of 6 days. Patients measured capillary glucose levels with a HemoCue~R (Angelholm, Sweden) system six to 10 times a day. In addition, two inpaticnt studies were performed between Days 1-3 and 4-6.